Harrow (HROW) News Today $31.52 +1.11 (+3.65%) Closing price 06/18/2025 04:00 PM EasternExtended Trading$31.46 -0.06 (-0.19%) As of 06/18/2025 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock HROW Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Harrow Appoints Mike Biega as Vice President of Investor Relations and CommunicationsJune 19 at 4:31 AM | finance.yahoo.comHarrow, Inc. (NASDAQ:HROW) Receives Consensus Rating of "Buy" from AnalystsJune 17 at 2:55 AM | americanbankingnews.comI Am Swimming In Dividends With +7% YieldsJune 13, 2025 | seekingalpha.comHarrow (NASDAQ:HROW) Earns Buy Rating from Analysts at BTIG ResearchJune 13, 2025 | americanbankingnews.comHarrow, Inc. (NASDAQ:HROW) Given Consensus Recommendation of "Buy" by BrokeragesHarrow, Inc. (NASDAQ:HROW - Get Free Report) has been given a consensus rating of "Buy" by the six research firms that are covering the firm, Marketbeat reports. Six equities research analysts have rated the stock with a buy rating. The average 12-month price objective among brokers that have issuJune 12, 2025 | marketbeat.comHarrow (NASDAQ:HROW) Now Covered by Analysts at BTIG ResearchBTIG Research started coverage on shares of Harrow in a research note on Thursday. They issued a "buy" rating and a $62.00 price objective for the company.June 12, 2025 | marketbeat.comWhat is William Blair's Estimate for Harrow Q2 Earnings?Harrow, Inc. (NASDAQ:HROW - Free Report) - Analysts at William Blair issued their Q2 2025 earnings per share estimates for Harrow in a research report issued to clients and investors on Tuesday, June 10th. William Blair analyst L. Hanbury-Brown expects that the company will earn $0.00 per share fJune 12, 2025 | marketbeat.comWilliam Blair Initiates Coverage of Harrow (HROW) with Outperform RecommendationJune 12, 2025 | msn.comHarrow wins new Outperform at William Blair after licensing deal for pain drugJune 10, 2025 | msn.comHarrow (NASDAQ:HROW) Shares Gap Up - Still a Buy?Harrow (NASDAQ:HROW) Shares Gap Up - Still a Buy?June 10, 2025 | marketbeat.comHarrow (NASDAQ:HROW) Coverage Initiated at William BlairWilliam Blair started coverage on Harrow in a report on Tuesday. They set an "outperform" rating for the company.June 10, 2025 | marketbeat.comHarrow acquires U.S. commercial rights to BYQLOVI from Formosa PharmaceuticalsJune 10, 2025 | msn.comHarrow Acquires U.S. Commercial Rights to BYQLOVI™ (Clobetasol Propionate Ophthalmic Suspension) 0.05% from Formosa PharmaceuticalsJune 9, 2025 | prnewswire.comHarrow Acquires U.S. Commercial Rights to BYQLOVI™ (Clobetasol Propionate Ophthalmic Suspension) 0.05% from Formosa PharmaceuticalsJune 9, 2025 | businesswire.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 29,262 Shares of Harrow, Inc. (NASDAQ:HROW)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in shares of Harrow, Inc. (NASDAQ:HROW - Free Report) by 89.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investoJune 8, 2025 | marketbeat.comHarrow (NASDAQ:HROW) Trading Down 4.7% - Here's WhyHarrow (NASDAQ:HROW) Stock Price Down 4.7% - Here's WhyJune 5, 2025 | marketbeat.comWellington Management Group LLP Sells 11,951 Shares of Harrow, Inc. (NASDAQ:HROW)Wellington Management Group LLP cut its holdings in Harrow, Inc. (NASDAQ:HROW - Free Report) by 11.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 91,228 shares of the company's stock after selling 11,951 shares durinJune 5, 2025 | marketbeat.comBank of America Corp DE Trims Stock Holdings in Harrow, Inc. (NASDAQ:HROW)Bank of America Corp DE lowered its stake in shares of Harrow, Inc. (NASDAQ:HROW - Free Report) by 62.6% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 47,392 shares of the company's stock after selling 79,254 shares during the period. Bank of America CoJune 5, 2025 | marketbeat.comNuveen Asset Management LLC Decreases Holdings in Harrow, Inc. (NASDAQ:HROW)Nuveen Asset Management LLC trimmed its holdings in shares of Harrow, Inc. (NASDAQ:HROW - Free Report) by 65.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 113,752 shares of the company's stock after sellJune 2, 2025 | marketbeat.comMillennium Management LLC Sells 101,671 Shares of Harrow, Inc. (NASDAQ:HROW)Millennium Management LLC cut its stake in Harrow, Inc. (NASDAQ:HROW - Free Report) by 60.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 67,262 shares of the company's stock after selling 101,671 sharJune 2, 2025 | marketbeat.comTwo Sigma Advisers LP Has $1.28 Million Holdings in Harrow, Inc. (NASDAQ:HROW)Two Sigma Advisers LP increased its position in shares of Harrow, Inc. (NASDAQ:HROW - Free Report) by 30.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 38,200 shares of the company's stock after purchaJune 1, 2025 | marketbeat.comHarrow (NASDAQ:HROW) Stock Price Up 3.9% - Time to Buy?Harrow (NASDAQ:HROW) Stock Price Up 3.9% - Should You Buy?May 31, 2025 | marketbeat.comB. Riley Brokers Reduce Earnings Estimates for HarrowHarrow, Inc. (NASDAQ:HROW - Free Report) - Investment analysts at B. Riley cut their Q2 2025 earnings per share (EPS) estimates for Harrow in a report issued on Wednesday, May 28th. B. Riley analyst M. Mamtani now forecasts that the company will post earnings per share of $0.01 for the quarter, dMay 31, 2025 | marketbeat.comInsiders Favor Harrow And 2 Other Leading Growth CompaniesMay 30, 2025 | finance.yahoo.comWhat is B. Riley's Estimate for Harrow FY2027 Earnings?Harrow, Inc. (NASDAQ:HROW - Free Report) - Analysts at B. Riley dropped their FY2027 earnings per share estimates for shares of Harrow in a research note issued to investors on Wednesday, May 28th. B. Riley analyst M. Mamtani now anticipates that the company will earn $4.46 per share for the yearMay 30, 2025 | marketbeat.comTwo Sigma Investments LP Has $5.04 Million Stock Position in Harrow, Inc. (NASDAQ:HROW)Two Sigma Investments LP increased its position in Harrow, Inc. (NASDAQ:HROW - Free Report) by 483.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 150,355 shares of the company's stock after purchasiMay 29, 2025 | marketbeat.comBNP Paribas Financial Markets Has $289,000 Stake in Harrow, Inc. (NASDAQ:HROW)BNP Paribas Financial Markets decreased its position in Harrow, Inc. (NASDAQ:HROW - Free Report) by 89.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 8,628 shares of the company's stock after selling 71,346 sharesMay 29, 2025 | marketbeat.comHarrow: Epic Growth & Operating Leverage On Full DisplayMay 28, 2025 | seekingalpha.comVoloridge Investment Management LLC Sells 27,139 Shares of Harrow, Inc. (NASDAQ:HROW)Voloridge Investment Management LLC lowered its stake in Harrow, Inc. (NASDAQ:HROW - Free Report) by 12.6% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 188,592 shares of the company's stocMay 27, 2025 | marketbeat.comDeutsche Bank AG Has $3.63 Million Holdings in Harrow, Inc. (NASDAQ:HROW)Deutsche Bank AG grew its stake in shares of Harrow, Inc. (NASDAQ:HROW - Free Report) by 100.9% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 108,064 shares of the company's stock after buying an additional 54,273 shares during the quMay 23, 2025 | marketbeat.comNorthern Trust Corp Increases Holdings in Harrow, Inc. (NASDAQ:HROW)Northern Trust Corp grew its stake in Harrow, Inc. (NASDAQ:HROW - Free Report) by 7.5% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 319,084 shares of the company's stock after acquiring an additional 22,266 shares durinMay 20, 2025 | marketbeat.comGraham Capital Management L.P. Makes New $392,000 Investment in Harrow, Inc. (NASDAQ:HROW)Graham Capital Management L.P. acquired a new position in shares of Harrow, Inc. (NASDAQ:HROW - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 11,671 shares of the company's stock,May 19, 2025 | marketbeat.comPrivate Capital Management LLC Decreases Stock Holdings in Harrow, Inc. (NASDAQ:HROW)Private Capital Management LLC cut its holdings in Harrow, Inc. (NASDAQ:HROW - Free Report) by 21.7% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,694,983 shares of the company's stock after sellingMay 17, 2025 | marketbeat.comNicholas Investment Partners LP Trims Position in Harrow, Inc. (NASDAQ:HROW)Nicholas Investment Partners LP cut its position in Harrow, Inc. (NASDAQ:HROW - Free Report) by 65.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 23,822 shares of the company's stoMay 17, 2025 | marketbeat.comEquities Analysts Issue Forecasts for Harrow FY2026 EarningsHarrow, Inc. (NASDAQ:HROW - Free Report) - Equities research analysts at HC Wainwright issued their FY2026 earnings per share (EPS) estimates for shares of Harrow in a report issued on Monday, May 12th. HC Wainwright analyst Y. Chen anticipates that the company will post earnings of $0.40 per shaMay 16, 2025 | marketbeat.comHC Wainwright Analysts Lower Earnings Estimates for HarrowHarrow, Inc. (NASDAQ:HROW - Free Report) - Analysts at HC Wainwright cut their Q2 2025 EPS estimates for Harrow in a note issued to investors on Monday, May 12th. HC Wainwright analyst Y. Chen now anticipates that the company will post earnings per share of $0.03 for the quarter, down from theirMay 15, 2025 | marketbeat.comJim Cramer on Harrow, Inc. (HROW) – “Eye Care’s a Good Biz – If It Makes Money, Don’t Walk Away Pre-Breakout”May 14, 2025 | msn.comHarrow (NASDAQ:HROW) Price Target Raised to $60.00HC Wainwright raised their price objective on Harrow from $57.00 to $60.00 and gave the company a "buy" rating in a research note on Monday.May 14, 2025 | marketbeat.comD. E. Shaw & Co. Inc. Increases Stock Position in Harrow, Inc. (NASDAQ:HROW)D. E. Shaw & Co. Inc. raised its position in Harrow, Inc. (NASDAQ:HROW - Free Report) by 6.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 664,714 shares of the company's stock after acquiring an additional 41,896 shaMay 14, 2025 | marketbeat.comHarrow, Inc. (NASDAQ:HROW) Shares Sold by Captrust Financial AdvisorsCaptrust Financial Advisors reduced its stake in shares of Harrow, Inc. (NASDAQ:HROW - Free Report) by 14.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 72,920 shares of the company's stock after selling 12,219 shares durinMay 14, 2025 | marketbeat.com24,624 Shares in Harrow, Inc. (NASDAQ:HROW) Acquired by Centiva Capital LPCentiva Capital LP purchased a new position in shares of Harrow, Inc. (NASDAQ:HROW - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 24,624 shares of the company's stock, valued at approximately $826,00May 11, 2025 | marketbeat.comHarrow, Inc. (HROW) Q1 2025 Earnings Call TranscriptMay 10, 2025 | seekingalpha.comHarrow Inc (HROW) Q1 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Market ...May 10, 2025 | finance.yahoo.comExamining the Future: Harrow's Earnings OutlookMay 9, 2025 | nasdaq.comHarrow Health Posts Larger Loss In Q1, But Retail Enthusiasm Grows As Dry Eye Disease Drug Drives RevenueMay 9, 2025 | msn.comHarrow Announces First-Quarter 2025 Financial ResultsMay 8, 2025 | businesswire.comBraidwell LP Buys 467,401 Shares of Harrow, Inc. (NASDAQ:HROW)Braidwell LP grew its stake in shares of Harrow, Inc. (NASDAQ:HROW - Free Report) by 106.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 907,039 shares of the company's stock after acquiring an additMay 8, 2025 | marketbeat.comHarrow (HROW) to Release Quarterly Earnings on MondayHarrow (NASDAQ:HROW) will be releasing its Q1 2025 earnings before the market opens on Monday, May 12. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-12-harrow-health-inc-stock/)May 7, 2025 | marketbeat.comFreestone Grove Partners LP Purchases New Holdings in Harrow, Inc. (NASDAQ:HROW)Freestone Grove Partners LP acquired a new position in Harrow, Inc. (NASDAQ:HROW - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 11,621 shares of the company's stock, valued at approxMay 7, 2025 | marketbeat.comInvesco Ltd. Lowers Position in Harrow, Inc. (NASDAQ:HROW)Invesco Ltd. lessened its holdings in shares of Harrow, Inc. (NASDAQ:HROW - Free Report) by 92.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 14,919 shares of the company's stock after selling 184,105 shares duMay 6, 2025 | marketbeat.com Get Harrow News Delivered to You Automatically Sign up to receive the latest news and ratings for HROW and its competitors with MarketBeat's FREE daily newsletter. Email Address HROW Media Mentions By Week HROW Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HROW News Sentiment▼0.820.57▲Average Medical News Sentiment HROW News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HROW Articles This Week▼114▲HROW Articles Average Week Get Harrow News Delivered to You Automatically Sign up to receive the latest news and ratings for HROW and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Zai Lab News Akero Therapeutics News Prestige Consumer Healthcare News PTC Therapeutics News Cytokinetics News Rhythm Pharmaceuticals News ACADIA Pharmaceuticals News Merus News Perrigo News Avidity Biosciences News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HROW) was last updated on 6/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Harrow, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Harrow With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
